Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-24-000030

Chief Medical Officer sold 642 shares at $25.14 ($16,140)

  • Chief Medical Officer acquired 2,162 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Gheuens Sarah · Chief Medical Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-02-12 Exercise or conversion : show line 1 in the form 10b5-1 +2,162 34,073 D
2024-02-14 Sale : show line 2 in the form 10b5-1 −642 $25.14 $16,140 33,431 D
Open-market sales · 642 sh · avg $25.14 · $16,140

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-02-12 Exercise or conversion : show line 3 in the form 10b5-1 Restricted stock units −2,162 0 D
Loading xslF345X05/wk-form4_1707951190.xml…